Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Anna Maria Raiola, MD, Sara Aquino, MD, Germana Beltrami, MD, Stefania Bregante, MD, Fabio Cruciani, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Anna Ghiso, MD, Francesca Gualandi, MD, Adalberto Ibatici, MD, Teresa Lamparelli, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Riccardo Varaldo, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3173.

https://doi.org/10.1182/blood.V128.22.3173.3173

Published: 2016

Journal Articles

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Carmen Di Grazia, MD, Simona Geroldi, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Nicoletta Colombo, PhD, Elisabetta Tedone, Silvia Luchetti, Teresa Lamparelli, Francesca Gualandi, MD, Adalberto Ibatici, MD, Stefania Bregante, Maria Teresa van Lint, Anna Maria Raiola, Alida Dominietto, MD, Riccardo Varaldo, Federica Galaverna, Anna Ghiso, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 1866.

https://doi.org/10.1182/blood.V126.23.1866.1866

Published: 2015

Journal Articles

Natural Killer (NK) Alloreactivity Seems Not to Play a Role in Preventing Leukemia Relapse in Unmanipulated Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide

Federica Galaverna, MD, Fabio Guolo, MD, Daniela Pende, MD, Alida Dominietto, MD, Raffaella Meazza, PhD, Michela Falco, PhD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Anna Ghiso, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Paola Minetto, MD, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 2033.

https://doi.org/10.1182/blood.V126.23.2033.2033

Published: 2015

Journal Articles

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Stefania Bregante, Alida Dominietto, MD, Anna Ghiso, Anna Maria Raiola, Francesca Gualandi, MD, Riccardo Varaldo, Carmen Di Grazia, MD, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Lucia Casarino, Sarah Pozzi, Elisabetta Tedone, Maria Teresa van Lint, MD, Federica Galaverna, Gianni Barosi, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 4336.

https://doi.org/10.1182/blood.V126.23.4336.4336

Published: 2015

Journal Articles

The Safety, Tolerability and Efficacy of Deferasirox in Older Patients with Transfusional Dependent Anemia

Eleonora Arboscello, MD, Lisette Del Corso, MD, Jacopo Agnelli Giacchello, MD, Enrico Balleari, MD, Andrea Bellodi, MD, Carmen Di Grazia, MD, Alida Dominietto, Serena Favorini, MD, Anna Ghiso, Martina Giovannini, MD, Elisa Molinari, MD, Chiara Salvetti, MD, Vera Sicbaldi, MD, Paolo Strada, Gianluca Ubezio, Maria Teresa Van Lint, MD, Luana Vignolo, Riccardo Ghio, PhD MD

Blood (2014) 124 (21): 2678.

https://doi.org/10.1182/blood.V124.21.2678.2678

Published: 2014

Journal Articles

Efficacy and Tolerability Of Frontline Oral Fludarabine and Cyclophosphamide Combination Therapy For Elderly Patients With Chronic B-Cell Lymphocytic Leukaemia and Low Grade Non Hodgkin Lymphoma

Micaela Bergamaschi, MD, Laura Mitscheunig, Fabio Guolo, MD, Anna Ghiso, Federica Galaverna, Maurizio Miglino, PHD, Marino Clavio, MD, Filippo Ballerini, PHD, Letizia Canepa, MD, Roberto Lemoli, Marco Gobbi, MD, Ivana Pierri, MD

Blood (2013) 122 (21): 5095.

https://doi.org/10.1182/blood.V122.21.5095.5095

Published: 2013

Journal Articles

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

Anna Maria Raiola, Anna Ghiso, Alida Dominietto, Carmen Di Grazia, Francesca Gualandi, Riccardo Varaldo, Federica Galaverna, Maria Teresa Van Lint, Teresa Lamparelli, Stefania Bregante, Maurizio Miglino, PHD, Filippo Ballerini, PHD, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 2103.

https://doi.org/10.1182/blood.V122.21.2103.2103

Published: 2013

Journal Articles

CD34+ Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation

Alessandra Stasia, MD, Anna Ghiso, Anna Maria Raiola, Federica Galaverna, Riccardo Varaldo, Francesca Gualandi, Alida Dominietto, Sarah Pozzi, Silvia Luchetti, Enrico Maria Pogliani, MD, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 3306.

https://doi.org/10.1182/blood.V122.21.3306.3306

Published: 2013

Journal Articles

Unmanipulated Haploidentical Bone Marrow Transplantation and Post-Transplant Cyclophosphamide for Hematologic Malignanices Following A Myeloablative Conditioning.

Andrea P Bacigalupo, Anna Maria Raiola, Alida Dominietto, Maria Teresa Van Lint, MD, Francesca Gualandi, Teresa Lamparelli, Stefania Bregante, Anna Ghiso, Carmen Di Grazia, Riccardo Varaldo

Blood (2012) 120 (21): 3034.

https://doi.org/10.1182/blood.V120.21.3034.3034

Published: 2012

Journal Articles

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Anna Ghiso, Annamaria Raiola, Francesca Gualandi, Alida Dominietto, Riccardo Varaldo, Maria Teresa van Lint, Stefania Bregante, Carmen Di Grazia, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Elisabetta Tedone, Andrea P Bacigalupo

Blood (2012) 120 (21): 1950.

https://doi.org/10.1182/blood.V120.21.1950.1950

Published: 2012

Journal Articles

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

Alida Dominietto, Anna Maria Raiola, Barbara Bruno, Maria Teresa van Lint, Francesco Frassoni, MD, Carmen Di Grazia, Francesca Gualandi, Stefania Bregante, Riccardo Varaldo, Anna Ghiso, Andrea Bacigalupo

Blood (2011) 118 (21): 3050.

https://doi.org/10.1182/blood.V118.21.3050.3050

Published: 2011

Journal Articles

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Nicoletta Colombo, Raffaella Grasso, Maurizio Miglino, Marino Clavio, Gianmatteo Pica, MD, Germana Beltrami, Micaela Bergamaschi, Carlo Marani, Antonia Cagnetta, Anna Ghiso, Laura Mitscheunig, Ivana Pierri, Filippo Ballerini, Letizia Canepa, Sara Aquino, Enrico De Astis, Angelo Michele Carella, Marco Gobbi

Blood (2009) 114 (22): 4675.

https://doi.org/10.1182/blood.V114.22.4675.4675

Published: 2009

NARROW

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Natural Killer (NK) Alloreactivity Seems Not to Play a Role in Preventing Leukemia Relapse in Unmanipulated Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

The Safety, Tolerability and Efficacy of Deferasirox in Older Patients with Transfusional Dependent Anemia

Efficacy and Tolerability Of Frontline Oral Fludarabine and Cyclophosphamide Combination Therapy For Elderly Patients With Chronic B-Cell Lymphocytic Leukaemia and Low Grade Non Hodgkin Lymphoma

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

CD34+ Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation

Unmanipulated Haploidentical Bone Marrow Transplantation and Post-Transplant Cyclophosphamide for Hematologic Malignanices Following A Myeloablative Conditioning.

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only